Seaweed polysaccharide-based nanoparticles: Preparation and applications for drug delivery

Polymers

Volumn 8, Issue 2, 2016, Pages

  Venkatesan, Jayachandran ^a   Anil, Sukumaran ^b   Kim, Se Kwon ^c   Shim, Min Suk ^a  

^a SolarLight Ltd   (South Korea)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c Pukyong National University   (South Korea)

Author keywords

Alginate; Carrageenan; Drug delivery; Fucoidan

Indexed keywords

ALGINATE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADABLE POLYMERS; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG PRODUCTS; DYES; EMULSIFICATION; ENCAPSULATION; GELATION; MOLECULES; NANOPARTICLES; PARTICLE SIZE; POLYELECTROLYTES; POLYSACCHARIDES; PROTEINS; SEAWEED;

ABUNDANT RESOURCES; CARRAGEENANS; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY VEHICLES; EFFICIENT DRUG DELIVERY; FUCOIDANS; SUSTAINED DRUG RELEASE; THERAPEUTIC MOLECULES;

TARGETED DRUG DELIVERY;

EID: 84960101401     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym8020030     Document Type: Review

References (202)

1. Smit, A. Medicinal and pharmaceutical uses of seaweed natural products: A review. J. Appl. Phycol. 2004, 16, 245-262.
2. Renn, D. Biotechnology and the red seaweed polysaccharide industry: Status, needs and prospects. Trends Biotechnol. 1997, 15, 9-14.
3. Araki, C. Seaweed polysaccharides. In Carbohydrate Chemistry of Substances of Biological Interests; Pergamon Press: London, UK, 1959; pp. 15-30.
4. Mori, R. Seaweed polysaccharides. Adv. Carbohydr. Chem. 1953, 8, 315.
5. Vera, J.; Castro, J.; Gonzalez, A.; Moenne, A. Seaweed polysaccharides and derived oligosaccharides stimulate defense responses and protection against pathogens in plants. Mar. Drugs 2011, 9, 2514-2525.
6. Rioux, L.E.; Turgeon, S.L.; Beaulieu, M. Characterization of polysaccharides extracted from brown seaweeds. Carbohydr. Polym. 2007, 69, 530-537.
7. Kraan, S. Algal Polysaccharides, Novel Applications and Outlook; INTECH Open Access Publisher: Rijeka, Croatia, 2012.
8. Venkatesan, J.; Bhatnagar, I.; Manivasagan, P.; Kang, K.-H.; Kim, S.-K. Alginate composites for bone tissue engineering: A review. Int. J. Biol. Macromol. 2015, 72, 269-281.
9. Horn, S.J. Bioenergy from brown seaweeds, 2000. Available online: http://hdl.handle.net/11250/245591 (accessed on 02 January 2016).
10. Kim, S.-K. Handbook of Marine Macroalgae: Biotechnology and Applied Phycology; John Wiley & Sons: New York City, NY, USA, 2011.
11. Panchanathan, M.; Jayachandran, V.; Se-Kwon, K. Marine algae: An important source of bioenergy production. In Marine Bioenergy; CRC Press: Boca Raton, FL, USA, 2015; pp. 45-70.
12. Panchanathan, M.; Se-Kwon, K. Introduction to marine bioenergy. In Marine Bioenergy; CRC Press: Boca Raton, FL, USA, 2015; pp. 3-12.
13. Wi, S.G.; Kim, H.J.; Mahadevan, S.A.; Yang, D.-J.; Bae, H.-J. The potential value of the seaweed Ceylon moss (Gelidium amansii) as an alternative bioenergy resource. Bioresour. Technol. 2009, 100, 6658-6660.
14. Venkatesan, J.; Lowe, B.; Anil, S.; Manivasagan, P.; Al Kheraif, A.A.; Kang, K.H.; Kim, S.K. Seaweed polysaccharides and their potential biomedical applications. Starch-Stärke 2015, 67, 381-390.
15. Sell, S.A.; Wolfe, P.S.; Garg, K.; McCool, J.M.; Rodriguez, I.A.; Bowlin, G.L. The use of natural polymers in tissue engineering: A focus on electrospun extracellular matrix analogues. Polymers 2010, 2, 522-553.
16. Pillai, O.; Panchagnula, R. Polymers in drug delivery. Curr. Opin. Chem. Biol. 2001, 5, 447-451.
17. Tiwari, P.; Panthari, P.; Katare, D.P.; Kharkwal, H. Natural polymers in drug delivery. World J. Pharm. Pharm. Sci. 2014, 3, 1395-1409.
18. Hubbell, J.A. Biomaterials in tissue engineering. Nat. Biotechnol. 1995, 13, 565-576.
19. Gerard, M.; Chaubey, A.; Malhotra, B. Application of conducting polymers to biosensors. Biosens. Bioelectron. 2002, 17, 345-359.
20. Cascone, M.G.; Sim, B.; Sandra, D. Blends of synthetic and natural polymers as drug delivery systems for growth hormone. Biomaterials 1995, 16, 569-574.
21. Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 2008, 60, 1650-1662.
22. Prajapati, V.D.; Maheriya, P.M.; Jani, G.K.; Solanki, H.K. Carrageenan: A natural seaweed polysaccharide and its applications. Carbohydr. Polym. 2014, 105, 97-112.
23. Rao, J.P.; Geckeler, K.E. Polymer nanoparticles: Preparation techniques and size-control parameters. Prog. Polym. Sci. 2011, 36, 887-913.
24. Sudhir, S.C.; Dennis, H.R.; Sinjan, D. Nanoparticles prepared using natural and synthetic polymers. In Nanoparticulate Drug Delivery Systems; CRC Press: Boca Raton, FL, USA, 2007; pp. 51-60.
25. Venugopal, V. Marine Polysaccharides: Food Applications; CRC Press: Boca Raton, FL, USA, 2011.
26. Jayakumar, R.; Menon, D.; Manzoor, K.; Nair, S.; Tamura, H. Biomedical applications of chitin and chitosan based nanomaterials-A short review. Carbohydr. Polym. 2010, 82, 227-232.
27. Skaugrud, Ø.; Hagen, A.; Borgersen, B.; Dornish, M. Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol. Genet. Eng. Rev. 1999, 16, 23-40.
28. Dash, M.; Chiellini, F.; Ottenbrite, R.M.; Chiellini, E. Chitosan-A versatile semi-synthetic polymer in biomedical applications. Prog. Polym. Sci. 2011, 36, 981-1014.
29. Agnihotri, S.A.; Mallikarjuna, N.N.; Aminabhavi, T.M. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release 2004, 100, 5-28.
30. De Campos, A.M.; Diebold, Y.; Carvalho, E.L.; Sánchez, A.; Alonso, M.J. Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity. Pharm. Res. 2004, 21, 803-810.
31. De Campos, A.M.; Sánchez, A.; Alonso, M.A.J. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 2001, 224, 159-168.
32. Li, L.; Chen, D.; Zhang, Y.; Deng, Z.; Ren, X.; Meng, X.; Tang, F.; Ren, J.; Zhang, L. Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system. Nanotechnology 2007, 18, 405102.
33. Nagpal, K.; Singh, S.K.; Mishra, D.N. Chitosan nanoparticles: A promising system in novel drug delivery. Chem. Pharm. Bull. 2010, 58, 1423-1430.
34. Narayanan, D.; Ninan, N.; Jayakumar, R.; Nair, S.V.; Menon, D. O-carboxymethyl chitosan nanoparticles for controlled release of non-steroidal anti-inflammatory drugs. Adv. Sci. Eng. Med. 2014, 6, 522-530.
35. Prabaharan, M. Chitosan-based nanoparticles for tumor-targeted drug delivery. Int. J. Biol. Macromol. 2015, 72, 1313-1322.
36. Saranya, N.; Moorthi, A.; Saravanan, S.; Devi, M.P.; Selvamurugan, N. Chitosan and its derivatives for gene delivery. Int. J. Biol. Macromol. 2011, 48, 234-238.
37. Tiyaboonchai, W. Chitosan nanoparticles: A promising system for drug delivery. Naresuan Univ. J. Sci. Technol. 2013, 11, 51-66.
38. Zhang, H.; Oh, M.; Allen, C.; Kumacheva, E. Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules 2004, 5, 2461-2468.
39. Paques, J.P.;van der Linden, E.;van Rijn, C.J.; Sagis, L.M. Preparation methods of alginate nanoparticles. Adv. Colloid Interface Sci. 2014, 209, 163-171.
40. Zhang, N.; Wardwell, P.R.; Bader, R.A. Polysaccharide-based micelles for drug delivery. Pharmaceutics 2013, 5, 329-352.
41. Martínez, A.; Fernández, A.; Pérez, E.; Teijón, J.; Benito, M.; Blanco, M. Polysaccharide-Based Nanoparticles for Controlled Release Formulations; INTECH Open Access Publisher: Rijeka, Croatia, 2012.
42. Namazi, H.; Heydari, A.; Fathi, F. Nanoparticles Based on Modified Polysaccharides; INTECH Open Access Publisher: Rijeka, Croatia, 2012.
43. Kulterer, M.R.; Reichel, V.E.; Kargl, R.; Köstler, S.; Sarbova, V.; Heinze, T.; Stana-Kleinschek, K.; Ribitsch, V. Functional polysaccharide composite nanoparticles from cellulose acetate and potential applications. Adv. Funct. Mater. 2012, 22, 1749-1758.
44. Saravanakumar, G.; Jo, D.-G.; H Park, J. Polysaccharide-based nanoparticles: A versatile platform for drug delivery and biomedical imaging. Curr. Med. Chem. 2012, 19, 3212-3229.
45. Posocco, B.; Dreussi, E.;de Santa, J.; Toffoli, G.; Abrami, M.; Musiani, F.; Grassi, M.; Farra, R.; Tonon, F.; Grassi, G. Polysaccharides for the delivery of antitumor drugs. Materials 2015, 8, 2569-2615.
46. Percival, E. The polysaccharides of green, red and brown seaweeds: Their basic structure, biosynthesis and function. Br. Phycol. J. 1979, 14, 103-117.
47. Barros, F.C.N.;da Silva, D.C.; Sombra, V.G.; Maciel, J.S.; Feitosa, J.P.A.; Freitas, A.L.P.;de Paula, R.C.M. Structural characterization of polysaccharide obtained from red seaweed Gracilaria caudata (J Agardh). Carbohydr. Polym. 2013, 92, 598-603.
48. Ermakova, S.; Kusaykin, M.; Trincone, A.; Tatiana, Z. Are multifunctional marine polysaccharides a myth or reality? Front. Chem. 2015, 3, 39.
49. Silva, T.H.; Alves, A.; Popa, E.G.; Reys, L.L.; Gomes, M.E.; Sousa, R.A.; Silva, S.S.; Mano, J.F.; Reis, R.L. Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches. Biomatter 2012, 2, 278-289.
50. Lee, K.Y.; Mooney, D.J. Alginate: Properties and biomedical applications. Prog. Polym. Sci. 2012, 37, 106-126.
51. Sosnik, A. Alginate particles as platform for drug delivery by the oral route: State-of-the-art. ISRN Pharm. 2014.
52. George, M.; Abraham, T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan-A review. J. Control. Release 2006, 114, 1-14.
53. Reis, C.P.; Neufeld, R.J.; Vilela, S.; Ribeiro, A.J.; Veiga, F. Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particles. J. Microencapsul. 2006, 23, 245-257.
54. You, J.-O. Efficient Gene Delivery with Calcium-Alginate Nanoparticles; ProQuest: Ann Arbor, MI, USA, 2006.
55. Ciofani, G.; Raffa, V.; Obata, Y.; Menciassi, A.; Dario, P.; Takeoka, S. Magnetic driven alginate nanoparticles for targeted drug delivery. Curr. Nanosci. 2008, 4, 212-218.
56. Vauthier, C.; Bouchemal, K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 2009, 26, 1025-1058.
57. Duceppe, N.; Tabrizian, M. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin. Drug Deliv. 2010, 7, 1191-1207.
58. Lertsutthiwong, P.; Rojsitthisak, P. Chitosan-alginate nanocapsules for encapsulation of turmeric oil. Die Pharm. An Int. J. Pharm. Sci. 2011, 66, 911-915.
59. Sun, J.; Tan, H. Alginate-based biomaterials for regenerative medicine applications. Materials 2013, 6, 1285-1309.
60. Paredes Juárez, G.A.; Spasojevic, M.; Faas, M.;de Vos, P. Immunological and technical considerations in application of alginate-based microencapsulation systems. Front. Bioeng. Biotechnol. 2014, 2.
61. Wang, J.; Wang, M.; Zheng, M.; Guo, Q.; Wang, Y.; Wang, H.; Xie, X.; Huang, F.; Gong, R. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Colloids Surf. B 2015, 129, 63-70.
62. Cheng, L.; Bulmer, C.; Margaritis, A. Characterization of novel composite alginate chitosan-carrageenan nanoparticles for encapsulation of BSA as a model drug delivery system. Curr. Drug Deliv. 2015, 12, 351-357.
63. Katuwavila, K.; Perera, A.; Karunaratne, V.; Karunaratne, D. Determination of in vitro release kinetics of doxorubicin from chitosan and chitosan-alginate nanoparticles. In Proceedings of the Peradeniya University International Research Sessions (iPURSE), Peradeniya, Sri Lanka, 4-5 July 2014; Volume 18.
64. Racoviťa, S.; Vasiliu, S.; Popa, M.; Luca, C. Polysaccharides based on micro-and nanoparticles obtained by ionic gelation and their applications as drug delivery systems. Rev. Roum. Chim. 2009, 54, 709-718.
65. Hudson, D.; Margaritis, A. Biopolymer nanoparticle production for controlled release of biopharmaceuticals. Crit. Rev. Biotechnol. 2014, 34, 161-179.
66. Machado, A.H.E.; Lundberg, D.; Ribeiro, A.J.; Veiga, F.J.; Lindman, B.; Miguel, M.G.; Olsson, U. Preparation of calcium alginate nanoparticles using water-in-oil (w/o) nanoemulsions. Langmuir 2012, 28, 4131-4141.
67. You, J.O.; Peng, C.A. Calcium-Alginate Nanoparticles Formed by Reverse Microemulsion as Gene Carriers, Macromolecular Symposia; Wiley Online Library: New York, NY, USA, 2005; pp. 147-153.
68. 125I sodium alginate-bovine serum albumin nanoparticles. World J. Gastroenterol. 1999, 5, 57-60.
69. Sarmento, B.; Ferreira, D.; Veiga, F.; Ribeiro, A. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr. Polym. 2006, 66, 1-7.
70. Motwani, S.K.; Chopra, S.; Talegaonkar, S.; Kohli, K.; Ahmad, F.J.; Khar, R.K. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation. Eur. J. Pharm. Biopharm. 2008, 68, 513-525.
71. Ahmad, Z.; Pandey, R.; Sharma, S.; Khuller, G. Alginate nanoparticles as antituberculosis drug carriers: Formulation development, pharmacokinetics and therapeutic potential. Indian J. Chest Dis. Allied Sci. 2006, 48, 171.
72. Arora, S.; Gupta, S.; Narang, R.K.; Budhiraja, R.D. Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. Pylori. Sci. Pharm. 2011, 79, 673-694.
73. Sarei, F.; Dounighi, N.M.; Zolfagharian, H.; Khaki, P.; Bidhendi, S.M. Alginate nanoparticles as a promising adjuvant and vaccine delivery system. Indian J. Pharm. Sci. 2013, 75, 442-449.
74. 2. Int. J. Biol. Macromol. 2014, 71, 141-146.
75. Raza, S.; Sabik, J.F.; Ainkaran, P.; Blackstone, E.H. Coronary artery bypass grafting in diabetics: A growing healthcare cost crisis. J. Thorac Cardiovasc. Surg. 2015, 150, 304-312.
76. Diabetes. Available online: http://www.who.int/mediacentre/factsheets/fs312/en/(accessed on 2 January 2016).
77. Mukhopadhyay, P.; Chakraborty, S.; Bhattacharya, S.; Mishra, R.; Kundu, P. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. Int. J. Biol. Macromol. 2015, 72, 640-648.
78. Reis, C.P.; Neufeld, R.; Ribeiro, A.J.; Veiga, F. Design of insulin-loaded alginate nanoparticles: Influence of the calcium ion on polymer gel matrix properties. Chem. Ind. Chem. Eng. Q. 2006, 12, 47-52.
79. Sarmento, B.; Ribeiro, A.; Veiga, F.; Ferreira, D.; Neufeld, R. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J. Nanosci. Nanotechnol. 2007, 7, 2833-2841.
80. Sarmento, B.; Ribeiro, A.; Veiga, F.; Sampaio, P.; Neufeld, R.; Ferreira, D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 2007, 24, 2198-2206.
81. Goycoolea, F.M.; Lollo, G.; Remunán-López, C.; Quaglia, F.; Alonso, M.J. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules 2009, 10, 1736-1743.
82. Wang, T.; He, N. Preparation, characterization and applications of low-molecular-weight alginate-oligochitosan nanocapsules. Nanoscale 2010, 2, 230-239.
83. Nesamony, J.; Singh, P.R.; Nada, S.E.; Shah, Z.A.; Kolling, W.M. Calcium alginate nanoparticles synthesized through a novel interfacial cross-linking method as a potential protein drug delivery system. J. Pharm. Sci. 2012, 101, 2177-2184.
84. Li, T.; Shi, X.W.; Du, Y.M.; Tang, Y.F. Quaternized chitosan/alginate nanoparticles for protein delivery. J. Biomed. Mater. Res. 2007, 83, 383-390.
85. Cancer Statistics, National Cancer Institute. Available online: http://www.cancer.gov/about-cancer/what-is-cancer/statistics (accessed on 2 January 2016).
86. Bhunchu, S.; Rojsitthisak, P. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy. Die Pharm. An Int. J. Pharm. Sci. 2014, 69, 563-570.
87. Alexis, F.; Pridgen, E.M.; Langer, R.; Farokhzad, O.C. Nanoparticle technologies for cancer therapy. In Drug Delivery; Springer: New York, NY, USA, 2010; pp. 55-86.
88. Rajaonarivony, M.; Vauthier, C.; Couarraze, G.; Puisieux, F.; Couvreur, P. Development of a new drug carrier made from alginate. J. Pharm. Sci. 1993, 82, 912-917.
89. Zhang, C.; Wang, W.; Wang, C.; Tian, Q.; Huang, W.; Yuan, Z.; Chen, X. Cytotoxicity of liver targeted drug-loaded alginate nanoparticles. Sci. China Ser. B 2009, 52, 1382-1387.
90. Zhang, C.; Wang, W.; Liu, T.; Wu, Y.; Guo, H.; Wang, P.; Tian, Q.; Wang, Y.; Yuan, Z. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials 2012, 33, 2187-2196.
91. Guo, H.; Lai, Q.; Wang, W.; Wu, Y.; Zhang, C.; Liu, Y.; Yuan, Z. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy. Int. J. Pharm. 2013, 451, 1-11.
92. Khdair, A.; Handa, H.; Mao, G.; Panyam, J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro. Eur. J. Pharm. Biopharm. 2009, 71, 214-222.
93. 3 hybrid nanoparticles for efficient codelivery of antitumor gene and drug. Mol. Pharm. 2012, 9, 2887-2893.
94. Zhao, D.; Zhuo, R.-X.; Cheng, S.-X. Alginate modified nanostructured calcium carbonate with enhanced delivery efficiency for gene and drug delivery. Mol. Biosyst. 2012, 8, 753-759.
95. Xing, J.; Deng, L.; Dong, A. Chitosan/alginate nanoparticles stabilized by poloxamer for the controlled release of 5-fluorouracil. J. Appl. Polym. Sci. 2010, 117, 2354-2359.
96. Nagarwal, R.C.; Kumar, R.; Pandit, J. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: In vitro characterization and in vivo study in rabbit eye. Eur. J. Pharm. Sci. 2012, 47, 678-685.
97. Das, R.K.; Kasoju, N.; Bora, U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomed. Nanotechnol. Biol. Med. 2010, 6, 153-160.
98. Aynie, I.; Vauthier, C.; Chacun, H.; Fattal, E.; Couvreur, P. Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 1999, 9, 301-312.
99. Gupta, V.K.; Karar, P. Optimization of process variables for the preparation of chitosan-alginate nanoparticles. Int. J Pharm Pharm. Sci. 2011, 3, 78-80.
100. Martinez, A.; Benito-Miguel, M.; Iglesias, I.; Teijon, J.; Blanco, M. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems. J. Biomed. Mater. Res. 2012, 100, 1467-1476.
101. Zhang, L.; Pornpattananangkul, D.; Hu, C.-M.; Huang, C.-M. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 2010, 17, 585-594.
102. Zahoor, A.; Sharma, S.; Khuller, G. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob. Agents 2005, 26, 298-303.
103. Ahmad, Z.; Pandey, R.; Sharma, S.; Khuller, G.K. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses. Int. J. Antimicrob. Agents 2006, 27, 409-416.
104. Choonara, Y.E.; Pillay, V.; Ndesendo, V.M.;du Toit, L.C.; Kumar, P.; Khan, R.A.; Murphy, C.S.; Jarvis, D.-L. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloids Surf. B 2011, 87, 243-254.
105. Ghaffari, S.; Varshosaz, J.; Haririan, I.; Khoshayand, M.R.; Azarmi, S.; Gazori, T. Ciprofloxacin loaded alginate/chitosan and solid lipid nanoparticles, preparation, and characterization. J. Dispers. Sci. Technol. 2012, 33, 685-689.
106. Chopra, M.; Kaur, P.; Bernela, M.; Thakur, R. Synthesis and optimization of streptomycin loaded chitosan-alginate nanoparticles. Int. J. Sci. Technol. Res. 2012, 1, 31-34.
107. Balaure, P.C.; Andronescu, E.; Grumezescu, A.M.; Ficai, A.; Huang, K.-S.; Yang, C.-H.; Chifiriuc, C.M.; Lin, Y.-S. Fabrication, characterization and in vitro profile based interaction with eukaryotic and prokaryotic cells of alginate-chitosan-silica biocomposite. Int. J. Pharm. 2013, 441, 555-561.
108. Zohri, M.; Alavidjeh, M.S.; Haririan, I.; Ardestani, M.S.; Ebrahimi, S.E.S.; Sani, H.T.; Sadjadi, S.K. A comparative study between the antibacterial effect of nisin and nisin-loaded chitosan/alginate nanoparticles on the growth of staphylococcus aureus in raw and pasteurized milk samples. Probiotics Antimicrob. Proteins 2010, 2, 258-266.
109. De, S.; Robinson, D. Polymer relationships during preparation of chitosan-alginate and poly-Llysine-alginate nanospheres. J. Control. Release 2003, 89, 101-112.
110. Boissiere, M.; Allouche, J.; Chanéac, C.; Brayner, R.; Devoisselle, J.-M.; Livage, J.; Coradin, T. Potentialities of silica/alginate nanoparticles as hybrid magnetic carriers. Int. J. Pharm. 2007, 344, 128-134.
111. Ciofani, G.; Raffa, V.; Menciassi, A.; Dario, P. Alginate and chitosan particles as drug delivery system for cell therapy. Biomed. Microdevices 2008, 10, 131-140.
112. Li, P.; Dai, Y.-N.; Zhang, J.-P.; Wang, A.-Q.; Wei, Q. Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine. Int. J. Biomed. Sci. 2008, 4, 221.
113. Sudakar, C.; Dixit, A.; Regmi, R.; Naik, R.; Lawes, G.; Naik, V.M.; Vaishnava, P.P.; Toti, U.; Panyam, J. FeO incorporated AOT-alginate nanoparticles for drug delivery. IEEE Trans. Magn. 2008, 44, 2800-2803.
114. Gazori, T.; Khoshayand, M.R.; Azizi, E.; Yazdizade, P.; Nomani, A.; Haririan, I. Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: Formulation, optimization and in vitro characterization. Carbohydr. Polym. 2009, 77, 599-606.
115. Lertsutthiwong, P.; Rojsitthisak, P.; Nimmannit, U. Preparation of turmeric oil-loaded chitosan-alginate biopolymeric nanocapsules. Mat. Sci. Eng. C 2009, 29, 856-860.
116. Azizi, E.; Namazi, A.; Haririan, I.; Fouladdel, S.; Khoshayand, M.R.; Shotorbani, P.Y.; Nomani, A.; Gazori, T. Release profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vector. Int. J. Nanomed. 2010, 5, 455.
117. Grillo, R.;de Melo, N.F.;de Araújo, D.R.;de Paula, E.; Rosa, A.H.; Fraceto, L.F. Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. J. Drug Target. 2010, 18, 688-699.
118. Yang, S.J.; Chang, S.M.; Tsai, K.C.; Chen, W.S.; Lin, F.H.; Shieh, M.J. Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells. J. Gene Med. 2010, 12, 168-179.
119. 3. J. Agric. Food. Chem. 2011, 59, 1962-1967.
120. Yang, S.-J.; Lin, F.-H.; Tsai, H.-M.; Lin, C.-F.; Chin, H.-C.; Wong, J.-M.; Shieh, M.-J. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials 2011, 32, 2174-2182.
121. Jain, S.; Amiji, M. Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system. Biomacromolecules 2012, 13, 1074-1085.
122. Liu, X.; Chen, X.; Li, Y.; Cui, Y.; Zhu, H.; Zhu, W. Preparation of superparamagnetic sodium alginate nanoparticles for covalent immobilization of candida rugosa lipase. J. Nanopart. Res. 2012, 14, 1-7.
123. Lu, C.; Liu, P. Effect of chitosan multilayers encapsulation on controlled release performance of drug-loaded superparamagnetic alginate nanoparticles. J. Mater. Sci. Mater. Med. 2012, 23, 393-398.
124. Zhu, X.; Su, M.; Tang, S.; Wang, L.; Liang, X.; Meng, F.; Hong, Y.; Xu, Z. Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery. Mol. Vis. 2012, 18, 1973-1982.
125. Ali, M.; Afzal, M.; Verma, M.; Misra-Bhattacharya, S.; Ahmad, F.J.; Dinda, A.K. Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, brugia malayi. Parasitol. Res. 2013, 112, 2933-2943.
126. Bagre, A.P.; Jain, K.; Jain, N.K. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment. Int. J. Pharm. 2013, 456, 31-40.
127. Marcato, P.D.; Adami, L.F.;de Melo Barbosa, R.; Melo, P.; Ferreira, I.R.;de Paula, L.; Duran, N.; Seabra, A.B. Development of a sustained-release system for nitric oxide delivery using alginate/chitosan nanoparticles. Curr. Nanosci. 2013, 9, 1-7.
128. Friedman, A.J.; Phan, J.; Schairer, D.O.; Champer, J.; Qin, M.; Pirouz, A.; Blecher-Paz, K.; Oren, A.; Liu, P.T.; Modlin, R.L. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: A targeted therapy for cutaneous pathogens. J. Investig. Dermatol. 2013, 133, 1231-1239.
129. 2 nanoparticles. Food Hydrocoll. 2013, 31, 428-434.
130. Kumar, S.; Bhanjana, G.; Sharma, A.; Sidhu, M.; Dilbaghi, N. Synthesis, characterization and on field evaluation of pesticide loaded sodium alginate nanoparticles. Carbohydr. Polym. 2014, 101, 1061-1067.
131. Manuja, A.; Kumar, S.; Dilbaghi, N.; Bhanjana, G.; Chopra, M.; Kaur, H.; Kumar, R.; Manuja, B.K.; Singh, S.K.; Yadav, S.C. Quinapyramine sulfate-loaded sodium alginate nanoparticles show enhanced trypanocidal activity. Nanomedicine 2014, 9, 1625-1634.
132. Shen, B.; Yang, S. Composition and Method for Preparing Alginate Nanocapsules. U.S. Patents 8, 449, 919 B2, 28 May 2013.
133. Panyam, J.; Chavanpatil, M.D. Polymer-Surfactant Nanoparticles for Sustained Release of Compounds. U.S. Patent 20, 110, 020, 457 A1, 27 January 2011.
134. Holdt, S.L.; Kraan, S. Bioactive compounds in seaweed: Functional food applications and legislation. J. Appl. Phycol. 2011, 23, 543-597.
135. Lordan, S.; Ross, R.P.; Stanton, C. Marine bioactives as functional food ingredients: Potential to reduce the incidence of chronic diseases. Mar. Drugs 2011, 9, 1056-1100.
136. Charalampopoulos, D.; Wang, R.; Pandiella, S.; Webb, C. Application of cereals and cereal components in functional foods: A review. Int. J. Food Microbiol. 2002, 79, 131-141.
137. Luo, M.; Shao, B.; Nie, W.; Wei, X.-W.; Li, Y.-L.; Wang, B.-L.; He, Z.-Y.; Liang, X.; Ye, T.-H.; Wei, Y.-Q. Antitumor and adjuvant activity of λ -carrageenan by stimulating immune response in cancer immunotherapy. Sci. Rep. 2015, 5.
138. Murad, H.; Ghannam, A.; Al-Ktaifani, M.; Abbas, A.; Hawat, M. Algal sulfated carrageenan inhibits proliferation of MDA-MB-231 cells via apoptosis regulatory genes. Mol. Med. Rep. 2015, 11, 2153-2158.
139. Sşen, M.; Avci, E.N. Radiation synthesis of poly (n-vinyl-2-pyrrolidone)-κ-carrageenan hydrogels and their use in wound dressing applications. I. Preliminary laboratory tests. J. Biomed. Mater. Res. 2005, 74, 187-196.
140. Malafaya, P.B.; Silva, G.A.; Reis, R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 2007, 59, 207-233.
141. Santo, V.E.; Frias, A.M.; Carida, M.; Cancedda, R.; Gomes, M.E.; Mano, J.F.; Reis, R.L. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 2009, 10, 1392-1401.
142. Rocha, P.M.; Santo, V.E.; Gomes, M.E.; Reis, R.L.; Mano, J.F. Encapsulation of adipose-derived stem cells and transforming growth factor β 1 in carrageenan-based hydrogels for cartilage tissue engineering. J. Bioact. Compatible Polym. 2011, 26, 493-507.
143. Mihaila, S.M.; Gaharwar, A.K.; Reis, R.L.; Marques, A.P.; Gomes, M.E.; Khademhosseini, A. Photocrosslinkable κ-carrageenan hydrogels for tissue engineering applications. Adv. Healthc. Mater. 2013, 2, 895-907.
144. Li, L.; Ni, R.; Shao, Y.; Mao, S. Carrageenan and its applications in drug delivery. Carbohydr. Polym. 2014, 103, 1-11.
145. Melo-Silveira, R.F.; Almeida-Lima, J.; Rocha, H.A.O. Application of marine polysaccharides in nanotechnology. In Marine Medicinal Glycomics; Nova Science Publishers, Inc.: New York, NY, USA, 2013; pp. 95-114.
146. Kadajji, V.G.; Betageri, G.V. Water soluble polymers for pharmaceutical applications. Polymers 2011, 3, 1972-2009.
147. Luo, Y.; Wang, Q. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery. Int. J. Biol. Macromol. 2014, 64, 353-367.
148. Rodrigues, S.; Cardoso, L.;da Costa, A.M.R.; Grenha, A. Biocompatibility and stability of polysaccharide polyelectrolyte complexes aimed at respiratory delivery. Materials 2015, 8, 5647-5670.
149. Rodrigues, S.; Costa, A.M.R.D.; Grenha, A. Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios. Carbohydr. Polym. 2012, 89, 282-289.
150. Pinheiro, A.C.; Bourbon, A.I.; Quintas, M.A.C.; Coimbra, M.A.; Vicente, A.A. K-carrageenan/chitosan nanolayered coating for controlled release of a model bioactive compound. Innov. Food Sci. Emerg. Technol. 2012, 16, 227-232.
151. Bulmer, C.; Margaritis, A.; Xenocostas, A. Encapsulation and controlled release of recombinant human erythropoietin from chitosan-carrageenan nanoparticles. Curr. Drug Del. 2012, 9, 527-537.
152. Grenha, A.; Gomes, M.E.; Rodrigues, M.; Santo, V.E.; Mano, J.F.; Neves, N.M.; Reis, R.L. Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J. Biomed. Mater. Res. A 2010, 92, 1265-1272.
153. Daniel-da-Silva, A.L.; Ferreira, L.; Gil, A.M.; Trindade, T. Synthesis and swelling behavior of temperature responsive κ-carrageenan nanogels. J. Colloid Interface Sci. 2011, 355, 512-517.
154. Rodrigues, S.; Cordeiro, C.; Seijo, B.; Remuñán-López, C.; Grenha, A. Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation. Carbohydr. Polym. 2015, 123, 369-380.
155. Dul, M.; Paluch, K.J.; Kelly, H.; Healy, A.M.; Sasse, A.; Tajber, L. Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-investigation of critical parameters governing their formation and characteristics. Carbohydr. Polym. 2015, 123, 339-349.
156. Mahdavinia, G.R.; Etemadi, H.; Soleymani, F. Magnetic/pH-responsive beads based on caboxymethyl chitosan and κ-carrageenan and controlled drug release. Carbohydr. Polym. 2015, 128, 112-121.
157. Daniel-Da-Silva, A.L.; Moreira, J.; Neto, R.; Estrada, A.C.; Gil, A.M.; Trindade, T. Impact of magnetic nanofillers in the swelling and release properties of κ-carrageenan hydrogel nanocomposites. Carbohydr. Polym. 2012, 87, 328-335.
158. Ale, M.T.; Mikkelsen, J.D.; Meyer, A.S. Important determinants for fucoidan bioactivity: A critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds. Mar. Drugs 2011, 9, 2106-2130.
159. Jiao, G.; Yu, G.; Zhang, J.; Ewart, H.S. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 2011, 9, 196-223.
160. Li, B.; Lu, F.; Wei, X.; Zhao, R. Fucoidan: Structure and bioactivity. Molecules 2008, 13, 1671-1695.
161. Dos Santos, M.A.; Grenha, A. Polysaccharide nanoparticles for protein and peptide delivery: Exploring less-known materials. Adv. Protein Chem. Struct. Biol. 2015, 98, 223-261.
162. Murakami, K.; Aoki, H.; Nakamura, S.; Nakamura, S.-i.; Takikawa, M.; Hanzawa, M.; Kishimoto, S.; Hattori, H.; Tanaka, Y.; Kiyosawa, T. Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings. Biomaterials 2010, 31, 83-90.
163. Sezer, A.D.; Cevher, E. Fucoidan: A versatile biopolymer for biomedical applications. In Active Implants and Scaffolds for Tissue Regeneration; Springer: New York, NY, USA, 2011; pp. 377-406.
164. Lee, H.M.; Kim, J.-K.; Cho, T.-S. Applications of ophthalmic biomaterials embedded with fucoidan. J. Ind. Eng. Chem. 2012, 18, 1197-1201.
165. Murakami, K.; Ishihara, M.; Aoki, H.; Nakamura, S.; Nakamura, S.I.; Yanagibayashi, S.; Takikawa, M.; Kishimoto, S.; Yokoe, H.; Kiyosawa, T. Enhanced healing of mitomycin c-treated healing-impaired wounds in rats with hydrosheets composed of chitin/chitosan, fucoidan, and alginate as wound dressings. Wound Repair Regen. 2010, 18, 478-485.
166. Pinheiro, A.C.; Bourbon, A.I.; Cerqueira, M.A.; Maricato, é.; Nunes, C.; Coimbra, M.A.; Vicente, A.A. Chitosan/fucoidan multilayer nanocapsules as a vehicle for controlled release of bioactive compounds. Carbohydr. Polym. 2014, 115, 1-9.
167. Lee, E.J.; Lim, K.H. Polyelectrolyte complexes of chitosan self-assembled with fucoidan: An optimum condition to prepare their nanoparticles and their characteristics. Korean J. Chem. Eng. 2014, 31, 664-675.
168. Lee, E.J.; Lim, K.H. Formation of chitosan-fucoidan nanoparticles and their electrostatic interactions: Quantitative analysis. J. Biosci. Bioeng. 2015, 121, 73-83.
169. Kimura, R.; Rokkaku, T.; Takeda, S.; Senba, M.; Mori, N. Cytotoxic effects of fucoidan nanoparticles against osteosarcoma. Mar. Drugs 2013, 11, 4267-4278.
170. Dantas-Santos, N.; Almeida-Lima, J.; Vidal, A.A.J.; Gomes, D.L.; Oliveira, R.M.; Pedrosa, S.S.; Pereira, P.; Gama, F.M.; Rocha, H.A.O. Antiproliferative activity of fucan nanogel. Mar. Drugs 2012, 10, 2002-2022.
171. Huang, Y.C.; Yang, Y.T. Effect of basic fibroblast growth factor released from chitosan-fucoidan nanoparticles on neurite extension. J. Tissue Eng. Regen. Med. 2013.
172. Huang, Y.C.; Kuo, T.H. O-carboxymethyl chitosan/fucoidan nanoparticles increase cellular curcumin uptake. Food Hydrocoll. 2015, 53, 261-269.
173. Da Silva, L.C.; Garcia, T.; Mori, M.; Sandri, G.; Bonferoni, M.C.; Finotelli, P.V.; Cinelli, L.P.; Caramella, C.; Cabral, L.M. Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity. Int. J. Nanomed. 2012, 7, 2975-2986.
174. Lira, M.C.B.; Santos-Magalhães, N.S.; Nicolas, V.; Marsaud, V.; Silva, M.P.C.; Ponchel, G.; Vauthier, C. Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles. Eur. J. Pharm. Biopharm. 2011, 79, 162-170.
175. Huang, Y.C.; Liu, T.J. Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles. Acta Biomater. 2012, 8, 1048-1056.
176. Liu, Y.; Yao, W.; Wang, S.; Geng, D.; Zheng, Q.; Chen, A. Preparation and characterization of fucoidan-chitosan nanospheres by the sonification method. J. Nanosci. Nanotechnol. 2014, 14, 3844-3849.
177. Senthilkumar, K.; Manivasagan, P.; Venkatesan, J.; Kim, S.-K. Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer. Int. J. Biol. Macromol. 2013, 60, 366-374.
178. Kim, E.J.; Park, S.Y.; Lee, J.-Y.; Park, J.H. Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterol. 2010, 10, 96.
179. Delma, C.R.; Srinivasan, G.P.; Raviprakash, N.; Manna, S.K.; Somasundaram, S.T.; Aravindan, N. Fucoidan from turbinaria conoides attenuates pancreatic cancer progession by regulating p53-NFκ B crosstalk. Cancer Res. 2015, 75, 5508-5508.
180. Atashrazm, F.; Lowenthal, R.M.; Woods, G.M.; Holloway, A.F.; Dickinson, J.L. Fucoidan and cancer: A multifunctional molecule with anti-tumor potential. Mar. Drugs 2015, 13, 2327-2346.
181. Kalimuthu, S.; Kim, S.-K. Fucoidan, a sulfated polysaccharides from brown algae as therapeutic target for cancer. In Handbook of Anticancer Drugs from Marine Origin; Springer: New York, NY, USA, 2015; pp. 145-164.
182. Park, H.Y.; Kim, G.-Y.; Moon, S.-K.; Kim, W.J.; Yoo, Y.H.; Choi, Y.H. Fucoidan inhibits the proliferation of human urinary bladder cancer T24 cells by blocking cell cycle progression and inducing apoptosis. Molecules 2014, 19, 5981-5998.
183. Lowenthal, R.M.; Fitton, J.H. Are seaweed-derived fucoidans possible future anti-cancer agents? J. Appl. Phycol. 2015, 27, 2075-2077.
184. Chen, S.; Zhao, Y.; Zhang, Y.; Zhang, D. Fucoidan induces cancer cell apoptosis by modulating the endoplasmic reticulum stress cascades. PLoS ONE 2014, 9, e108157.
185. Huang, Y.C.; Lam, U.I. Chitosan/fucoidan ph sensitive nanoparticles for oral delivery system. J. Chin. Chem. Soc. 2011, 58, 779-785.
186. Fu, Y.; Gao, X.; Wan, Y.; Zhang, J.; Kong, D.; Wang, Z.; Zhao, Y. Dendritic nanoconjugate containing optimum folic acid for targeted intracellular curcumin delivery. RSC Adv. 2014, 4, 46020-46023.
187. Singh, R.; Lillard, J.W. Targeted delivery of curcumin to improve therapeutic outcome in breast cancer. Cancer Res. 2014, 74, 4476.
188. Prasad, S.; Tyagi, A.K.; Aggarwal, B.B. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res. Treat. 2014, 46, 2-18.
189. Rao, W.; Zhang, W.; Poventud-Fuentes, I.; Wang, Y.; Lei, Y.; Agarwal, P.; Weekes, B.; Li, C.; Lu, X.; Yu, J. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomater. 2014, 10, 831-842.
190. Anitha, A.; Sreeranganathan, M.; Chennazhi, K.P.; Lakshmanan, V.-K.; Jayakumar, R. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded n, O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies. Eur. J. Pharm. Biopharm. 2014, 88, 238-251.
191. Lee, K.W.; Jeong, D.; Na, K. Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment. Carbohydr. Polym. 2013, 94, 850-856.
192. Fitton, J.H.; Stringer, D.N.; Karpiniec, S.S. Therapies from fucoidan: An update. Mar. Drugs 2015, 13, 5920-5946.
193. Kanapathipillai, M.; Brock, A.; Ingber, D.E. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv. Drug Deliv. Rev. 2014, 79, 107-118.
194. Lale, S.V.; Aravind, A.; Kumar, D.S.; Koul, V. As1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy. Biomacromolecules 2014, 15, 1737-1752.
195. Thambi, T.; Deepagan, V.; Yoon, H.Y.; Han, H.S.; Kim, S.-H.; Son, S.; Jo, D.-G.; Ahn, C.-H.; Suh, Y.D.; Kim, K. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 2014, 35, 1735-1743.
196. Bertrand, N.; Wu, J.; Xu, X.; Kamaly, N.; Farokhzad, O.C. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014, 66, 2-25.
197. Xu, X.; Ho, W.; Zhang, X.; Bertrand, N.; Farokhzad, O. Cancer nanomedicine: From targeted delivery to combination therapy. Trends Mol. Med. 2015, 21, 223-232.
198. Qi, H.; Sheng, J. The antihyperlipidemic mechanism of high sulfate content ulvan in rats. Mar. Drugs 2015, 13, 3407-3421.
199. Dash, M.; Samal, S.K.; Bartoli, C.; Morelli, A.; Smet, P.F.; Dubruel, P.; Chiellini, F. Biofunctionalization of ulvan scaffolds for bone tissue engineering. ACS Appl. Mater. Interfaces 2014, 6, 3211-3218.
200. Efthimiadou, E.K.; Metaxa, A.-F.; Kordas, G. Modified polysaccharides for drug delivery. Polysacch. Bioact. Biotechnol. 2015, 1805-1835.
201. Graiff, A.; Ruth, W.; Kragl, U.; Karsten, U. Chemical characterization and quantification of the brown algal storage compound laminarin-A new methodological approach. J. Appl. Phycol. 2015.
202. Douglas, K.L.; Tabrizian, M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J. Biomater. Sci. Polym. Ed. 2005, 16, 43-56.